We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,156.00
Bid: 12,124.00
Ask: 12,128.00
Change: -14.00 (-0.12%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET PRE-OPEN: Barratt Profit Up; Interserve Gets Debt Deal

Wed, 06th Feb 2019 07:46

LONDON (Alliance News) - Stock prices in London on Wednesday are set to pull back from Tuesday's rally, while the pound remained below the USD1.30 mark after disappointing UK data released earlier in the week.In early company news, Barratt Developments said interim profit jumped amid higher revenue and stronger margins, while Victrex warned of a weaker first quarter, and Interserve reached a deal to cut debt via issuing just under GBP500 million in fresh equity. Due at midday are annual results form GlaxoSmithKline.IG says futures indicate the FTSE 100 index of large-caps to open 11.27 points lower at 7,166.10 on Wednesday. The FTSE 100 index closed up 2.0%, or 143.24 points, at 7,177.37 on Tuesday.After Tuesday's "bumper" move higher, stocks in London are set to pull back slightly on Wednesday, said CMC Markets chief market analyst Michael Hewson."Investors piled back into equity markets, sending the FTSE 100 to three-month highs, and European stocks to their highest levels in two months. The rise in the FTSE was helped by a weaker pound as well as a well-received set of numbers from oil giant BP," explained Hewson. Sterling had slumped on Tuesday after the latest UK services Purchasing Managers' Index came in at 50.1 in January, down from 51.2 in December and only marginally above the stagnation mark of 50. The pound was quoted at USD1.2929 early Wednesday, soft compared to USD1.2936 at the London equities close on Tuesday and remaining substantially below USD1.3059 as at the equities close on Monday.The services data on Tuesday followed news on Monday that UK construction growth eased further in January to its weakest level in ten months, while on Friday last week figures showed the country's manufacturing sector made a lacklustre start to 2019, slipping to its lowest level in three months.In company news, housebuilder Barratt Developments reported a double-digit rise in half-year profit.Revenue for the six months to December 31 rose 7.2% to GBP2.13 billion from GBP1.99 billion a year ago, as completions rose 4.1% to 7,622. Pretax profit jumped 19% year-on-year to GBP408.0 million as the company's gross margin improved by 200 basis points to 22.6%.The home builder raised its interim dividend by 12% to 9.6p. The FTSE 100 constituent said trading is in line with expectations and it is "confident" in achieving a "good financial and operational performance" in its current financial year. Barratt said it intends to pay a special return of GBP175 million in November 2019, as previously announced, and to demonstrate management's confidence it has proposed to pay a further GBP175 million in November 2020.Smaller peer Redrow said revenue in the half-year to December 31 grew 9% to GBP970 million as pretax profit increased 5% to GBP185 million. Legal completions rose 12% to 2,970The firm boosted its interim dividend by 11% to 10p. In addition to this, Redrow proposed a 30p per share return to shareholders through a 'B' share scheme. "The market during the run up to the festive period and the first two weeks of 2019 was subdued by macroeconomic and political uncertainty. However, sales over the last three weeks have bounced-back with reservations running at similar levels to last year's strong market activity," said Redrow's outgoing chair, Steve Morgan.Drugmaker AstraZeneca said the US Food & Drug Administration has granted Orphan Drug Designation to Fasenra for the treatment of hypereosinophilic syndrome. The FDA grants this designation to treatments of rare diseases or disorders that affect fewer than 200,000 people in the US.Water firm Severn Trent said it continues to expect a full-year trading performance in line with expectations. The blue-chip firm said its capital programme is progressing well and it is on track to deliver its "biggest capital spend in a decade. Victrex said it had a weaker start to its financial year, though has seen a pick-up in recent months. The high performance polymer firm said first quarter revenue was down 18% on last year at GBP64.1 million, with sales volumes of 822 tonnes down 22% year-on-year. "Pleasingly, January and February saw some initial improvement, although given our Q1 performance, the first half is expected to be much weaker overall, compared to the prior year. Our expectations for the second half are unchanged, with new projects and reduced headwinds supporting our assumptions," said Chief Executive Jakob Sigurdsson.Struggling support services firm Interserve said it has reached an agreement to cut debt via issuing new equity, and separately said it has received a letter from a shareholder requesting the removal of the majority of the board.Interserve said it has agreed a deleveraging plan in principle with its lender, bonding provider and the pension trustee, which is expected to result in the firm's net debt being reduced to GBP275 million. This will be done through the issue of GBP480 million in fresh Interserve equity. Interserve currently has a market capitalisation of GBP149.7 million, meaning existing shareholders face significant dilution.The new Interserve equity will be provisionally placed with existing lenders and subject to "claw back in full" by existing shareholders through a fully pre-emptive open offer."Whilst Interserve's objective remains to implement a fully consensual transaction, Interserve is also actively preparing alternative plans to ensure the proposed transaction can be implemented in the event that shareholder approval is not forthcoming," the company noted.Separately, Coltrane Master Fund has requisitioned a general meeting of Interserve, in which it has proposed the removal of Glyn Barker, Mark Whiteling, Russell King, Anne Fahy, Nick Salmon, Gareth Edwards, Dougie Sutherland and Nicholas Pollard as directors of Interserve. Coltrane does, however, continue to support Chief Executive Debbie White and is not seeking her removal. White is the only member of the Interserve board that Coltrane is not looking to remove.Atlas Mara said it is undertaking a strategic review and also announced Bob Diamond will step down as chair and return to his previous role of non-executive director.The African bank investor said it will be looking to reduce exposure in non-core markets, accelerate an agricultural finance platform, achieve the consolidation of the Union Bank of Nigeria, and develop a digital banking platform.In addition, Atlas Mara founder Diamond has decided to move from his role as chair and return to being a non-executive director on the board. Diamond assumed the role of chair on an interim basis, the company explained. Atlas Mara has appointed Michael Wilkerson, a non-executive director, to assume the role of executive chair.Still to come in Wednesday's UK corporate calendar are annual results from pharmaceuticals giant GlaxoSmithKline.In the US on Tuesday, Wall Street ended higher, with the Dow Jones Industrial Average closing up 0.7%, the S&P 500 up 0.5% and Nasdaq Composite gaining 0.7%.After the New York close, entertainment giant Walt Disney reported a fall in profit as revenue edged marginally lower. California-based Disney's first-quarter profit dropped to USD2.79 billion or USD1.86 per share from USD4.42 billion or USD2.91 per share a year before. The previous year's bottom line included a USD1.6 billion one-time tax benefit associated with US federal tax reforms. Revenue for the quarter was relatively flat at USD15.30 billion compared to USD15.35 billion a year before. Focus on Tuesday evening in the US was on US President Donald Trump's State of the Union address, though investors looking for a "fresh trading catalyst" were left disappointed, said Jasper Lawler, head of research at London Capital Group."The US dollar remained steady following President Trump's address. Whilst the President touched on Chinese trade relations and the budget there was nothing new for traders to sink their teeth into," said Lawler. Urging unity and cooperation across party lines, Trump on Tuesday hailed the country's economy while honing in on his signature issues of illegal immigration and a wall on the border with Mexico during his State of the Union address.In a response to Trump's speech, House Speaker Nancy Pelosi accused the president of "fear-mongering and manufacturing a crisis at the border".Trump's insistence on the wall led to a partial government shutdown in December and January, and funding again runs out on February 15, with no deal in sight.In Asia on Wednesday, the Japanese Nikkei 225 index closed closed up 0.1%. Financial markets in China and Hong Kong were closed for the Lunar New Year holiday. Trump said he would meet North Korean leader Kim Jong Un in Vietnam on February 27-28 for their second summit. "As part of a bold new diplomacy, we continue our historic push for peace on the Korean Peninsula," he told Congress in his State of the Union address.In the economic calendar on Wednesday are German factory orders at 0700 GMT followed by the US trade balance at 1330 GMT.

More News
25 Mar 2024 09:04

LONDON MARKET OPEN: FTSE 100 treads water, FTSE 250 declines

(Alliance News) - The FTSE 100 in London traded flat early Monday, while the pound remained below the USD1.26 mark, as Bank of England Governor Andrew Bailey suggested rate cuts may happen soon.

Read more
25 Mar 2024 08:40

TOP NEWS: AstraZeneca wins US approval for rare nervous system disease

(Alliance News) - AstraZeneca PLC on Monday said its Ultomiris treatment has been approved by the US Food & Drug Administration as the first and only long-acting C5 complement inhibitor to treat neuromyelitis optica spectrum disorder in adults.

Read more
25 Mar 2024 07:59

LONDON BRIEFING: AstraZeneca wins US approval, Kingfisher profit down

(Alliance News) - London's FTSE 100 is set to open lower on Monday, giving back some of last week's progress, when equities were boosted by hope of interest rate cuts.

Read more
25 Mar 2024 07:23

AstraZeneca gets FDA approval for Ultomiris treatment

(Sharecast News) - AstraZeneca has announced that its autoimmune disease treatment Ultomiris has been given the green light by US regulators.

Read more
21 Mar 2024 16:43

AstraZeneca's Tagrisso successful in treating lung cancer

(Alliance News) - AstraZeneca PLC on Thursday reported positive findings following a phase III trial of its lung cancer Tagrisso treatment.

Read more
19 Mar 2024 08:56

TOP NEWS: AstraZeneca to buy Fusion in deal worth over USD2 billion

(Alliance News) - AstraZeneca PLC on Tuesday said it will buy Fusion Pharmaceuticals Inc, a Canada-based clinical-stage biopharmaceutical company developing "next-generation" radioconjugates.

Read more
19 Mar 2024 07:05

AstraZeneca to buy US-listed Fusion Phrama for $2bn

(Sharecast News) - AstraZeneca said it had agreed to buy biopharmaceutical company Fusion Pharmaceuticals for up to $2bn.

Read more
18 Mar 2024 16:09

UK dividends calendar - next 7 days

Tuesday 19 March 
Jarvis Securities PLCdividend payment date
Wednesday 20 March 
Virgin Money UK PLCdividend payment date
Thursday 21 March 
abrdn Asia Focus PLCdividend payment date
abrdn Private Equity Opportunities Trust PLCex-dividend payment date
AIB Group PLCex-dividend payment date
Beazley PLCex-dividend payment date
BlackRock World Mining Trust PLCex-dividend payment date
British American Tobacco PLCex-dividend payment date
Chemring Group PLCex-dividend payment date
CLS Holdings PLCex-dividend payment date
Conduit Holdings Ltdex-dividend payment date
Craneware PLCex-dividend payment date
Crest Nicholson Holdings PLCex-dividend payment date
Diverse Income Trust PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
FW Thorpe PLCex-dividend payment date
Glanbia PLCex-dividend payment date
GlobalData PLCex-dividend payment date
Globalworth Real Estate Investments Ltdex-dividend payment date
Goodwin PLCex-dividend payment date
Gore Street Energy Storage Fund PLCex-dividend payment date
Hargreaves Services PLCex-dividend payment date
HgCapital Trust PLCex-dividend payment date
Hikma Pharmaceuticals PLCex-dividend payment date
Jardine Matheson Holdings LDex-dividend payment date
London Finance & Investment Group PLCex-dividend payment date
Maven Income & Growth VCT 3 PLCex-dividend payment date
Maven Income & Growth VCT 5 PLCex-dividend payment date
MTI Wireless Edge Ltdex-dividend payment date
Nichols PLCex-dividend payment date
NWF Group PLCex-dividend payment date
Palace Capital PLCex-dividend payment date
Pearson PLCex-dividend payment date
Pembroke VCT B PLCex-dividend payment date
Primorus Investments PLCex-dividend payment date
Schroders PLCex-dividend payment date
Triple Point Energy Transition PLCex-dividend payment date
Tristel PLCex-dividend payment date
VPC Specialty Lending Investments PLCdividend payment date
Friday 22 March 
easyJet PLCdividend payment date
FRP Advisory Group PLCdividend payment date
Gulf Investment Fund PLCdividend payment date
Henderson Opportunities Trust PLCdividend payment date
Hercules Site Services PLCdividend payment date
Impax Asset Management Group PLCdividend payment date
JLEN Environmental Assets Group Ltddividend payment date
JPMorgan Multi-Asset Growth & Income PLCdividend payment date
Mattioli Woods PLCdividend payment date
Mobeus Income & Growth 2 VCT PLCdividend payment date
Mobeus Income & Growth 4 VCT PLCdividend payment date
Ramsdens Holdings PLCdividend payment date
Riverstone Credit Opportunities Income PLCdividend payment date
Ruffer Investment Co Ltddividend payment date
Samuel Heath & Sons PLCdividend payment date
Troy Income & Growth Trust PLCdividend payment date
Unilever PLCdividend payment date
Monday 25 March 
AstraZeneca PLCdividend payment date
Endeavour Mining PLCdividend payment date
Mountview Estates PLCdividend payment date
Shell PLCdividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 14-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
18 Mar 2024 14:08

AstraZenca hails Imfinzi and Lynparza results on endometrial cancer

(Alliance News) - AstraZeneca PLC on Monday reported positive findings following the analysis of results from a phase III probe of its Imfinzi and Lynparza cancer treatments.

Read more
14 Mar 2024 10:01

TOP NEWS: AstraZeneca buys France's Amolyt Pharma for USD1 billion

(Alliance News) - AstraZeneca PLC on Thursday said it has struck a deal to acquire Amolyt Pharma SAS, strengthening its late-stage rare disease pipeline.

Read more
14 Mar 2024 07:52

LONDON BRIEFING: Astra makes USD1.05 billion buy; Halma backs outlook

(Alliance News) - London's FTSE 100 is set to tread water after the opening bell sounds on Thursday, as investors look to a batch of US data to come in the early afternoon.

Read more
14 Mar 2024 07:16

AstraZeneca snaps up rare disease specialist Amolyt for $1.05bn

(Sharecast News) - Biopharma giant AstraZeneca has announced the acquisition of French biotech firm Amolyt Pharma for up to $1.05bn to beef up its late-stage rare disease pipeline.

Read more
8 Mar 2024 06:00

Astra, Sanofi's antibody 90% effective against RSV in infants - CDC

(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.

Read more
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.